Flagship Pioneering Inc.'s Net Worth

Trade with PublicCompare Brokers
$0

Estimate Recalculated Nov 1, 2024 11:16AM EST

Who is Flagship Pioneering Inc.

Flagship Pioneering Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Moderna, Inc., Kaleido Biosciences, Inc., BG Medicine, Inc., Omega Therapeutics, Inc., Seres Therapeutics, Inc., Foghorn Therapeutics Inc., Codiak BioSciences, Inc., Sigilon Therapeutics, Inc., Evelo Biosciences, Inc., Axcella Health Inc., HELICOS BIOSCIENCES CORP, and ACCELERON PHARMA INC.

SEC CIK

Flagship Pioneering Inc.'s CIK is 0001400240

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sana Biotechnology, Inc.

Investor
Updated Feb 14, 2024
Form 4
—
2.73M
$5.50
$15.00M
Feb 14, 2024
2.73M
Purchase
—Feb 12
Form 4
-32.03%
-11.78M
——
Sep 15, 2023
25.58M
Disposition
—Sep 13
Form 4
—
—
——
Feb 10, 2021
34.24M
Options
—Feb 08
Form 3
————
Feb 03, 2021
—
—
——
Showing 4 results

Moderna, Inc.

Investor
Updated Dec 13, 2018
Form 4
—
—
——
Dec 13, 2018
58.81M
Options
—Dec 11
Form 3
————
Dec 07, 2018
11.46M
—
——
Showing 2 results

Kaleido Biosciences, Inc.

Investor
Updated Mar 06, 2019
Form 4
-21.29%
-10.14M
$15.00
$14.00M
Mar 06, 2019
39.98M
Buy-Options
—Mar 04
Form 3
————
Feb 27, 2019
2.50M
—
——
Showing 2 results

BG Medicine, Inc.

Investor
Updated Jul 29, 2015
Form 4
-0.52%
-302.00
$1.21
-$16.34
Jul 29, 2015
1.33M
Sale
—Jul 27
Form 4
-0.63%
-4.98K
$1.21
-$232.42
Jul 29, 2015
1.33M
Sale
—Jul 27
Form 4
—
1.47M
$1.70
$2.00M
Jul 16, 2015
1.47M
Purchase
—Jul 14
Form 4
-92.56%
-2.31M
$0.24
$174.72
Dec 05, 2014
5.02M
Sale
—Dec 03 - Dec 04
Form 4
-100.00%
-694.93K
$0.24
$198.60
Dec 05, 2014
7.27M
Sale
—Dec 03 - Dec 04
Form 4
-100.00%
-98.83K
$0.24
$21.10
Dec 05, 2014
7.92M
Sale
—Dec 03 - Dec 04
Form 4
-100.00%
-98.61K
$0.24
$20.72
Dec 05, 2014
8.01M
Sale
—Dec 03 - Dec 04
Form 4
33.80%
2.00M
$2.00
$4.00M
Feb 01, 2013
8.19M
Purchase
—Jan 30
Form 4
-100.00%
-298.22K
$2.93
-$22.15
Aug 22, 2012
6.19M
Sale
—Aug 20 - Aug 21
Form 4
-100.00%
-131.01K
$1.99
-$10.38
May 23, 2012
6.46M
Sale
—May 21 - May 23
Form 4
-64.80%
-193.13K
——
Sep 20, 2011
6.57M
Disposition
—Sep 19
Form 4
-310.66%
-6.31M
$3.51
$6.09M
Feb 11, 2011
6.85M
Buy-Options
—Sep 27 - Feb 09
Form 3
————
Feb 03, 2011
2.03M
—
——
Showing 13 results

Omega Therapeutics, Inc.

Investor
Updated Feb 27, 2023
Form 4
60.26%
3.32M
$5.78
$19.21M
Feb 27, 2023
29.23M
Purchase
—Feb 27
Form 4
-72.15%
-61.40M
$17.00
—
Aug 05, 2021
25.90M
Buy-Options
—Aug 03
Form 4
-72.15%
-61.40M
$17.00
—
Aug 05, 2021
25.90M
Buy-Options
—Aug 03
Form 3
————
Jul 29, 2021
2.20M
—
——
Form 3
————
Jul 29, 2021
2.20M
—
——
Showing 5 results

Foghorn Therapeutics Inc.

Investor
Updated May 24, 2024
Form 4
—
3.63M
$5.51
$20.00M
May 24, 2024
3.63M
Purchase
—May 22
Form 4
-45.30%
-10.50M
$16.00
—
Oct 29, 2020
12.67M
Buy-Options
—Oct 27
Form 3
————
Oct 22, 2020
—
—
——
Showing 3 results

Codiak BioSciences, Inc.

Investor
Updated Oct 13, 2020
Form 3
————
Oct 13, 2020
485.95K
—
——
Showing 1 results

Sigilon Therapeutics, Inc.

Investor
Updated Aug 15, 2023
Form 4
-100.00%
-797.72K
$14.92
-$11.90M
Aug 15, 2023
—
Disposition
—Aug 11
Form 4
—
—
——
Dec 10, 2020
10.37M
Options
—Dec 08
Form 3
————
Dec 03, 2020
—
—
——
Showing 3 results

Evelo Biosciences, Inc.

Investor
Updated Jul 13, 2023
Form 4
366.75%
5.41M
$2.31
$12.50M
Jul 13, 2023
7.93M
Purchase
—Jul 11
Form 4
288.55%
27.40M
$1.46
$40.00M
Jun 01, 2022
50.43M
Purchase
—May 27
Form 3
————
Jul 01, 2020
3.98M
—
——
Showing 3 results

Seres Therapeutics, Inc.

Investor
Updated Jul 07, 2022
Form 4
294.92%
8.74M
$3.15
$27.53M
Jul 07, 2022
23.49M
Purchase
—Jul 05
Form 4
-39.84%
-7.91M
——
Nov 25, 2020
15.05M
Disposition
—Nov 23
Form 3
————
Jun 28, 2019
8.89M
—
——
Showing 3 results

ACCELERON PHARMA INC

Investor
Updated Sep 18, 2013
Form 3
————
Sep 18, 2013
4.87K
—
——
Showing 1 results

HELICOS BIOSCIENCES CORP

Investor
Updated Sep 22, 2009
Form 4
3.38%
403.75K
——
Sep 22, 2009
12.35M
Purchase
—Sep 18
Form 4
—
5.55K
——
Aug 10, 2009
5.56K
Grant
—Aug 06
Form 4
414.33%
13.79M
——
Dec 29, 2008
17.12M
Purchase
—Dec 23
Form 4
—
5.55K
——
Jun 13, 2008
5.56K
Grant
—Jun 11
Form 4
—
11.11K
——
Nov 30, 2007
11.11K
Grant
—Jul 27
Form 4
-75.45%
-10.23M
$9.00
—
May 31, 2007
3.33M
Buy-Options
—May 30
Form 3
————
May 24, 2007
120.12K
—
——
Showing 7 results

Axcella Health Inc.

Investor
Updated Oct 17, 2022
Form 3
————
Oct 17, 2022
3.05M
—
——
Showing 1 results
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved